Whenacquiring tissue biopsy samples is not viable, CTC detection serves as an effective method for identifying anaplastic lymphoma kinase (ALK) gene rearrangements in NSCLC patients [85]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.